Piezo1 facilitates optimal T cell activation during tumor challenge

Area of Science:

• Immunology
• Cancer Biology
• Mechanobiology

Background:

• Functional effector T cells are vital for anti-tumor responses.
• T cell function involves differentiation, infiltration, and cytotoxicity within the tumor microenvironment (TME).
• The role of Piezo1, a mechanosensitive channel on T cells, in cancer immunity is largely unknown.

Purpose of the Study:

• To investigate the role of Piezo1 in CD4+ and CD8+ T cell function during anti-tumor immune responses.
• To determine if Piezo1 deletion in T cells impairs anti-tumor immunity in vivo.

Main Methods:

• Utilized mice with T cell-specific Piezo1 deletion (P1KO) challenged with T cell-dependent tumor models.
• Analyzed tumor growth rates, immune cell infiltration (CD4:CD8 ratio) in lymphoid organs and TME.
• Assessed T cell activation phenotypes (CD25, PD-1) in P1KO and wild-type mice.

Main Results:

• P1KO mice exhibited more aggressive tumors, higher growth rates, and unresponsiveness to immunotherapy.
• A decreased CD4:CD8 ratio was observed in P1KO mice, inversely correlating with tumor size.
• Impaired CD4+ helper T cell responses and sub-optimal CD8+ T cell activation (CD25loPD-1hi) were noted in P1KO mice.

Conclusions:

• Piezo1 is essential for optimizing T cell activation and anti-tumor immunity.
• Disruption of Piezo1 on T cells hinders inflammatory responses, leading to immune evasion and tumor progression.
• Targeting Piezo1 may represent a novel strategy to enhance cancer immunotherapy.